Abstract: I welcome you to the fourth issue of the IEEE Communications Surveys and Tutorials in 2021. This issue includes 23 papers covering different aspects of communication networks. In particular, ...
InnoCare’s BTK inhibitor, orelabrutinib, has displayed promising efficacy during a Phase IIb trial in systemic lupus erythematosus (SLE), which will see the drug progress to a Phase III registrational ...
American beverage manufacture Anheuser-Busch has announced its acquisition of a majority stake in BeatBox, a rapidly growing player in the alcoholic ready-to-drink (RTD) beverage sector. This deal ...
Jeff Schaffnit discusses Sanofi's advancements in BTK inhibitors and promising results for hemophilia A therapies at ASH 2025, enhancing treatment options. Managed Healthcare Executive spoke with Jeff ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback